Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice

Clinical trial NCT06018181 · COMPLETED

Trial details

NCT number: NCT06018181
Sponsor: Dongzhimen Hospital, Beijing
Status: COMPLETED
Study type: OBSERVATIONAL

Ischemic Stroke, Acute

Start date: 2023-09-28
Primary completion: 2025-08-28
Enrollment: 2408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.